In This Article:
-
Shop Cash NOI Growth: 17.7% increase.
-
Medicaid Rate Increase: Estimated at roughly 7%, 200 basis points higher than last year.
-
Medicare Market Basket Increase: Finalized at 4.2%.
-
Normalized FFO per Share: $0.35, up $0.01 from the first quarter.
-
Normalized AFFO per Share: $0.36, up $0.01 from the first quarter.
-
Net Debt to Adjusted EBITDA Ratio: 5.45x as of June 30, 2024.
-
Liquidity: $906 million, consisting of $36 million in unrestricted cash and $870 million in available borrowings.
-
Quarterly Cash Dividend: $0.30 per share, representing 83% payout of second-quarter normalized AFFO per share.
-
Same-Store Portfolio Revenue Growth: 6.8% year over year.
-
Canadian Communities Cash NOI Growth: 23.9% year over year.
-
RevPOR Increase: 3.1% year over year.
-
Net Income Guidance: $0.48 to $0.51 per share for full-year 2024.
-
FFO Guidance: $1.33 to $1.36 per share for full-year 2024.
-
Normalized FFO Guidance: $1.36 to $1.39 per share for full-year 2024.
-
Adjusted FFO Guidance: $1.39 to $1.42 per share for full-year 2024.
-
Normalized Adjusted FFO Guidance: $1.41 to $1.44 per share for full-year 2024.
Release Date: August 08, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Sabra Health Care REIT Inc (NASDAQ:SBRA) reported a 17.7% growth in shop cash NOI, indicating strong operational performance.
-
Senior housing and skilled nursing occupancy increased, with EBITDARM rent coverage improving for both asset classes.
-
The company announced approximately $136 million in new investments, showcasing active growth and expansion efforts.
-
Medicaid rate increases are estimated to be roughly 7%, with the top 5 SNF tenants experiencing a 10.6% increase, enhancing revenue potential.
-
Labor costs, including contract labor, are at their lowest level since March 2021, with agency costs down 50% from a year ago, improving cost efficiency.
Negative Points
-
Behavioral segment rent coverage was down, indicating volatility and unpredictability in this business line.
-
Cash G&A expenses increased by $2 million due to performance-based compensation adjustments, impacting overall cost structure.
-
Cash interest expense rose by $900,000 due to higher borrowings under the revolving credit facility, affecting financial leverage.
-
The company recognized $900,000 of non-recurring business interruption insurance income last quarter, which did not recur this quarter.
-
The investment impact on 2024 earnings is muted, with most benefits expected in 2025, delaying immediate financial gains.